High-frequency stimulation in Parkinson's disease: more or less?

Abstract : Deep-brain stimulation at high frequency is now considered the most effective neurosurgical therapy for movement disorders. An electrode is chronically implanted in a particular area of the brain and, when continuously stimulated, it significantly alleviates motor symptoms. In Parkinson's disease, common target nuclei of high-frequency stimulation (HFS) are ventral thalamic nuclei and basal ganglia nuclei, such as the internal segment of the pallidum and the subthalamic nucleus (STN), with a preference for the STN in recent years. Two fundamental mechanisms have been proposed to underlie the beneficial effects of HFS: silencing or excitation of STN neurons. Relying on recent experimental data, we suggest that both are instrumental: HFS switches off a pathological disrupted activity in the STN (a 'less' mechanism) and imposes a new type of discharge in the upper gamma-band frequency that is endowed with beneficial effects (a 'more' mechanism). The intrinsic capacity of basal ganglia and particular STN neurons to generate oscillations and shift rapidly from a physiological to a pathogenic pattern is pivotal in the operation of these circuits in health and disease.
Type de document :
Article dans une revue
Trends in Neurosciences, Elsevier, 2005, 28 (4), pp.209-16. 〈10.1016/j.tins.2005.02.005〉
Liste complète des métadonnées

Contributeur : Roman Tyzio <>
Soumis le : mardi 18 mai 2010 - 14:45:24
Dernière modification le : jeudi 18 janvier 2018 - 01:58:09
Document(s) archivé(s) le : mercredi 30 novembre 2016 - 23:53:16


 Accès restreint
Fichier visible le : jamais

Connectez-vous pour demander l'accès au fichier




Liliana Garcia, Giampaolo D'Alessandro, Bernard Bioulac, Constance Hammond. High-frequency stimulation in Parkinson's disease: more or less?. Trends in Neurosciences, Elsevier, 2005, 28 (4), pp.209-16. 〈10.1016/j.tins.2005.02.005〉. 〈inserm-00484473〉



Consultations de la notice